- Active Ingredients
Product Documentation
-
View RMM (Topiramate Epilepsy Patient guide)
Last updated on this site: 08 Jul 2024
View RMM (Topiramate Migraine Patient guide)Last updated on this site: 08 Jul 2024
View RMM (Topiramate Patient Card)Last updated on this site: 08 Jul 2024
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintTopiramate Accord 50mg Film-coated Tablets
- PL Number:
- 20075/0146
- MA Holder:
- Accord Healthcare Limited
- Product Classification:
-
POM
- Product Status:
- Active
Product Documentation
-
View Patient Information Leaflet (PIL- Topiramate Accord 25mg, 50mg, 100mg, 200mg Film-coated Tablets)
Last updated on this site: 05 Sep 2024
To update sections 1, 4.3, 4.4, 4.5 and 4.6 of the SmPC, PIL, Carton and Patient Card in line with CHM advice regarding EMEA/H/A-31/1520 Article 31 referral: risk of neurodevelopmental disorders associated with in utero exposure to AEDs.
Additional updates:
- Editorial and formatting updates to SmPC sections 4.3, 4.4, 4.5, 4.6 and the PIL.
- QRD updates have been made to the PIL.
- Editorial updates to the Foil and Carton including removal of NN.
View Summary of Product Characteristics (SmPC- Topiramate Accord 50mg Film-coated Tablets)Last updated on this site: 18 Nov 2024
To correct the transcription error from embossed to debossed in description of core & coated tablets. Consequently, section 3 of the SmPC and the PIL have been updated.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaint
For any further assistance, please get in touch.